Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Evaluating the Efficacy and Safety of a Microbiome-Focused Oral Food Supplement in Adults With Moderate Evaporative Dry Eye Disease Associated With Meibomian Gland Dysfunction
Conditions
Interventions
Dietary Supplement: Microbiome-targeted oral supplement
Placebo
Locations
3
Turkey (Türkiye)
T.C. İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
Istanbul, Turkey (Türkiye)
Istinye University
Istanbul, Turkey (Türkiye)
Medipol University
Istanbul, Turkey (Türkiye)
Start Date
March 1, 2026
Primary Completion Date
June 30, 2026
Completion Date
November 30, 2026
Last Updated
April 13, 2026
NCT07463950
NCT07363824
NCT07396441
NCT05865379
NCT05865457
NCT07298811
Lead Sponsor
Varol TUNALI
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions